These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 17360380)

  • 1. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.
    Ide K; Wang H; Tahara H; Liu J; Wang X; Asahara T; Sykes M; Yang YG; Ohdan H
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5062-6. PubMed ID: 17360380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47.
    Wang H; VerHalen J; Madariaga ML; Xiang S; Wang S; Lan P; Oldenborg PA; Sykes M; Yang YG
    Blood; 2007 Jan; 109(2):836-42. PubMed ID: 17008545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages.
    Jung SH; Hwang JH; Kim SE; Young Kyu K; Park HC; Lee HT
    Xenotransplantation; 2017 May; 24(3):. PubMed ID: 28393401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice.
    Waern JM; Yuan Q; Rüdrich U; Becker PD; Schulze K; Strick-Marchand H; Huntington ND; Zacher BJ; Wursthorn K; DiSanto JP; Guzman CA; Manns MP; Ott M; Bock M
    Hepatology; 2012 Oct; 56(4):1479-88. PubMed ID: 22535707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPα inhibitory signaling in mice.
    Teraoka Y; Ide K; Morimoto H; Tahara H; Ohdan H
    PLoS One; 2013; 8(3):e58359. PubMed ID: 23472187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD47-SIRPα signalling system: its physiological roles and therapeutic application.
    Murata Y; Kotani T; Ohnishi H; Matozaki T
    J Biochem; 2014 Jun; 155(6):335-44. PubMed ID: 24627525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.
    Barclay AN; Van den Berg TK
    Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro.
    Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H
    Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47.
    Wang C; Wang H; Ide K; Wang Y; Van Rooijen N; Ohdan H; Yang YG
    Cell Transplant; 2011; 20(11-12):1915-20. PubMed ID: 21535911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages.
    Lv Z; Bian Z; Shi L; Niu S; Ha B; Tremblay A; Li L; Zhang X; Paluszynski J; Liu M; Zen K; Liu Y
    J Immunol; 2015 Jul; 195(2):661-71. PubMed ID: 26085683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.
    Chen J; Zhong MC; Guo H; Davidson D; Mishel S; Lu Y; Rhee I; Pérez-Quintero LA; Zhang S; Cruz-Munoz ME; Wu N; Vinh DC; Sinha M; Calderon V; Lowell CA; Danska JS; Veillette A
    Nature; 2017 Apr; 544(7651):493-497. PubMed ID: 28424516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A membrane-type surfactant protein D (SP-D) suppresses macrophage-mediated cytotoxicity in swine endothelial cells.
    Jiaravuthisan P; Maeda A; Takakura C; Wang HT; Sakai R; Shabri AM; Lo PC; Matsuura R; Kodama T; Eguchi H; Okuyama H; Miyagawa S
    Transpl Immunol; 2018 Apr; 47():44-48. PubMed ID: 29425774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.
    Iwamoto C; Takenaka K; Urata S; Yamauchi T; Shima T; Kuriyama T; Daitoku S; Saito Y; Miyamoto T; Iwasaki H; Kitabayashi I; Itoh K; Kishimoto J; Kohda D; Matozaki T; Akashi K
    Exp Hematol; 2014 Mar; 42(3):163-171.e1. PubMed ID: 24269920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.
    Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD
    Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.
    Tsai RK; Rodriguez PL; Discher DE
    Blood Cells Mol Dis; 2010 Jun; 45(1):67-74. PubMed ID: 20299253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hybrid CL-SP-D molecule has the potential to regulate xenogeneic rejection by human neutrophils more efficiently than CD47.
    Iemitsu K; Sakai R; Maeda A; Gadomska K; Kogata S; Yasufuku D; Matsui J; Masahata K; Kamiyama M; Eguchi H; Matsumura S; Kakuta Y; Nagashima H; Okuyama H; Miyagawa S
    Transpl Immunol; 2024 Jun; 84():102020. PubMed ID: 38452982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.
    Liu Y; Tong Q; Zhou Y; Lee HW; Yang JJ; Bühring HJ; Chen YT; Ha B; Chen CX; Yang Y; Zen K
    J Mol Biol; 2007 Jan; 365(3):680-93. PubMed ID: 17070842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo.
    Ayi K; Lu Z; Serghides L; Ho JM; Finney C; Wang JCY; Liles WC; Kain KC
    Infect Immun; 2016 Jul; 84(7):2002-2011. PubMed ID: 27091932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.
    Veillette A; Chen J
    Trends Immunol; 2018 Mar; 39(3):173-184. PubMed ID: 29336991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells.
    Andrejeva G; Capoccia BJ; Hiebsch RR; Donio MJ; Darwech IM; Puro RJ; Pereira DS
    J Immunol; 2021 Feb; 206(4):712-721. PubMed ID: 33431660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.